BY ULRICH QUISTGAARD
-
Company that infected European patients with multi-resistant bacteria has now been identified
The contract producer that Sandoz used to supply the contaminated antibiotic Dicillin is positioned in Cyprus and declines to touch upon its position within the case.
-
Novo Nordisk will have to speed up pace to reach Wegovy sales target
There has actually been a minor decline in the variety of brand-new Wegovy individuals in the United States considering that May, however Chief Executive Officer Lars Fruergaard Jø…
-
Ambu maintains goal of Russian exit in 2024: “We are de facto out of Russia”
It’s a lawful fight for pharmaceutical firm Ambu to liquidate its subsidiary in Russia, yet Chief Executive Officer Britt Meelby Jensen stays certain that it will certainly b…
-
Coloplast investigates long-term benefits of ostomy platform: “Necessary for price talks with authorities”
Coloplast has actually begun a medical test of its electronic ostomy system Heylo, and the outcomes will certainly be made use of to discuss a far better rate, describes CFO Anders…
-
First mpox vaccines on their way to Africa — at a slow speed and a high price
The very first 10,000 Bavarian Nordic injections get on their means to Africa, yet the rate makes the shots hard to reach to lots of nations, movie critics have actually explained.
-
Leo Pharma will explore other options after failed phase III trial
The prospect TMB-001, which has actually set you back Leo Pharma a considerable quantity, stopped working to reveal a pertinent therapy impact versus the skin illness genetic ichth…
-
Coloplast has launched new catheter for women in four markets
After introducing its brand-new technical catheter Luja for males in a vast array of markets around the globe, the ladies’s variation is currently going into the very same ma…
-
Genmab CEO “too busy” for Leo Pharma board as own firm enters next phase
Genmab is getting into a brand new part in its growth that can require further focus and time from CEO Jan Van de Winkel, who has due to this fact stepped down from Leo Pharma’s Bo…
-
Genmab limits own sales to two markets: “It is easy to spread yourself too thin”
Chief Executive Officer Jan Van de Winkel highlights the requirement for companions in difficult markets like China and smaller sized markets where the Danish business has no strat…
-
A strange disease has taken hold of British politics
A once-sensible nation remains in the hold of millenarianism …Read More